Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NGIND.BOthis companyNG Industries Ltd.	₹100.10	24.68×	1.28×	2.61×	15.29×	268.2%	55.0%	7.3%	10.6%	5.2%	2.7%	3.8%	0.05×	0.08×	16.38×	1.55×	2.7%	3	12.09	2	C+
ANG.BOANG Lifesciences India Limited	₹36.93	-2.19×	0.46×	0.26×	141.24×	-50.6%	10.2%	-6.1%	-11.9%	-21.0%	-3.6%	14.0%	1.5×	106.97×	-0.71×	0.97×	0.0%	3	0.43	1	C-
BACPHAR.BOBacil Pharma Limited	₹16.82	43×	2.7×	0×	-270.7×	-93.7%	0.0%	0.0%	0.0%	6.3%	-1.0%	1.1%	0×	2.32×	0×	0.68×	0.0%	2	2.81	3	B-
BALAXI.NSBalaxi Pharmaceuticals Limited	₹22.66	60.27×	0.34×	0.31×	17.26×	-101.9%	41.7%	1.9%	0.5%	0.6%	0.4%	-52.9%	0.23×	5.79×	1.36×	4.51×	0.0%	5	2.08	1	D+
CMMHOSP.BOChennai Meenakshi Multispeciality Hospital Limited	₹35.11	-22.01×	-7.99×	0.66×	35.59×	-9.0%	50.5%	-3.7%	-3.0%	36.3%	-14.6%	-0.6%	-3.46×	6.39×	-1.51×	0.67×	0.0%	3	—	2	C
MEDICAPQ.BOMedi-Caps Limited	₹21.07	-9.51×	0.26×	2.32×	-3.02×	-58.8%	-37.2%	-90.1%	-24.4%	-2.7%	-9.9%	-27.0%	0×	0.05×	-862.95×	17.34×	0.0%	2	—	2	C
Peer median	—	-2.19×	0.34×	0.31×	17.26×	-58.8%	10.2%	-3.7%	-3.0%	0.6%	-3.6%	-0.6%	0×	5.79×	-0.71×	0.97×	0.0%	3	2.08	2	—